Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort:
Hottest Latest Alphabetical (A-Z) Alphabetical (Z-A)
Type:
All Topic Review Biography
Topic Review
Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Chemotherapy-induced peripheral neuropathy (CIPN) is widely recognized as a potentially severe toxicity that often leads to dose reduction or discontinuation of cancer treatment. Symptoms may persist despite discontinuation of chemotherapy and quality of life can be severely compromised. The clinical symptoms of CIPN, and the cellular and molecular targets involved in CIPN, are just as diverse as the wide variety of anticancer agents that cause peripheral neurotoxicity.
  • 561
  • 13 Jan 2022
Topic Review
HIV-Related Stigma
This notwithstanding, HIV continues to be a global public health issue. Many HIV patients died from acquired immune deficiency syndrome (AIDS) related illnesses globally. Without addressing HIV-related stigma, 2030 (SDG 3) will be a very distant reality, as HIV-related stigma has been identified as a major drawback in HIV counselling and testing (VCT) uptake and ART utilization and adherence.
  • 561
  • 13 Jun 2022
Topic Review
Vaccine and Monkeypox
The monkeypox virus (MPV) is a double-stranded DNA virus belonging to the Poxviridae family, Chordopoxvirinae subfamily, and Orthopoxvirus genus. It was called monkeypox because it was first discovered in monkeys, in a Danish laboratory, in 1958. Preventing the transmission and infection of MPV is associated with different challenges. The primary strategy of prevention would be vaccination. 
  • 559
  • 24 Oct 2022
Topic Review
Subarachnoid Hemorrhage
The incidence of hemorrhagic stroke in the general population accounts for approximately 20% of all the strokes, with 5% due to subarachnoid hemorrhage (SAH). The morbidity and mortality remains high for this patient population. For aneurysmal SAH, 30% of patients die and 50% of survivors have long-term cognitive deficits that preclude their return to work. The two most important determinants of outcome after SAH are initial hemorrhage severity and secondary brain injury due to early brain injury (EBI) and delayed cerebral ischemia (DCI). EBI occurs in 12% of patients, develops 1–3 days after SAH and is characterized by blood–brain barrier (BBB) disruption, neuronal cell death, neuroinflammation and cerebral edema. DCI occurs in ~30% of patients, develops 4–12 days after SAH and is characterized by large artery vasospasm, distal autoregulatory dysfunction, microvessel thrombosis and cortical spreading depression. Though many strategies to prevent EBI and DCI have been explored over the years, none have proven efficacious. New therapies are desperately needed to treat these conditions.
  • 559
  • 29 Jun 2021
Topic Review
Mediterranean Dietary Patterns During Pregnancy
Pregnancy outcomes for both mother and child are affected by many environmental factors. The importance of pregnancy for ‘early life programming’ in the first 1,000 days of life is well established and maternal nutrition is an important factor contributing to a favourable environment for developing offspring. Results show that being on a Mediterranean Diet during pregnancy is associated with favourable outcomes for both maternal and offspring health, particularly for gestational diabetes in mothers and congenital defects in offspring.
  • 559
  • 30 Sep 2021
Topic Review
Artificial Intelligence and COVID-19 Pandemic
The COVID-19 pandemic has worked as a catalyst, pushing governments, private companies, and healthcare facilities to design, develop, and adopt innovative solutions to control it, as is often the case when people are driven by necessity. After 18 months since the first case, it is time to think about the pros and cons of such technologies, including artificial intelligence—which is probably the most complex and misunderstood by non-specialists—in order to get the most out of them, and to suggest future improvements and proper adoption. 
  • 558
  • 05 Aug 2021
Topic Review
Physiological Effects of Covid-19 and Exercise
The world has been severely challenged by the Coronavirus Disease (COVID-19) outbreak since the early 2020s. Worldwide, there have been more than 66 million cases of infection and over 3,880,450 million deaths caused by this highly contagious disease. All sections of the population including those who are affected, who are not affected and those who have recovered from this disease are suffering physiologically. Physiological effects of COVID-19 may be managed by exercise management as a prevention strategy. Moderate exercise including walking, yoga, and tai-chi to name but a few exercise regimes are critical in preventing COVID-19 and its complications.  
  • 558
  • 29 Dec 2021
Topic Review
Meibomian Gland Dysfunction
Meibomian gland dysfunction (MGD) is the leading cause of dry eye disease and loss of ocular surface homeostasis. Increasingly, several observational clinical studies suggest that dyslipidemia (elevated blood cholesterol, triglyceride, or lipoprotein levels) can initiate the development of MGD. 
  • 557
  • 23 Nov 2021
Topic Review
Fibrinogen in Hypofibrinogenemia
Congenital fibrinogen disorders are diseases associated with a bleeding tendency; however, there are also reports of thrombotic events. Fibrinogen plays a role in the pathogenesis of thrombosis due to altered plasma concentrations or modifications to fibrinogen’s structural properties, which affect clot permeability, resistance to lysis, and its stiffness. Several distinct types of genetic change and pathogenetic mechanism have been described in patients with bleeding and a thrombotic phenotype, including mutations affecting synthesis or processing in three fibrinogen genes.
  • 556
  • 02 Mar 2022
Topic Review
Lobomycosis Epidemiology and Management
Lobomycosis is a chronic disease caused by Lacazia loboi, which is endemic to the Amazon rainforest, where it affects forest dwellers in Brazil. There is no disease control program and no official therapeutic protocol. This situation contributes to an unknown disease prevalence and unmet needs of people disabled by this disease who seek access to treatment. An effective therapy for lobomycosis has been found following decades of research led by the State Dermatology Program of Acre in the Amazon rainforest, where the largest number of cases occur. This discovery opened new avenues for future studies.
  • 556
  • 26 May 2022
  • Page
  • of
  • 183
Featured Entry Collections
>>

Featured Books

>>
Encyclopedia of Social Sciences
Encyclopedia of COVID-19
Encyclopedia of Fungi
Encyclopedia of Digital Society, Industry 5.0 and Smart City
Video Production Service
Feedback